Despite thalidomide’s dark past, researchers are investigating it as a potential COVID-19 treatment

Research output: Contribution to specialist publicationArticle

Abstract

In the midst of the coronavirus pandemic, researchers have turned to existing medicines to see whether they can be repurposed to treat COVID-19.

Antiviral medicines such as remdesivir and favipiravir that prevent the virus from reproducing itself are amongst many medicines being tested. Some cough syrups are even being investigated.

And surprisingly, the drug thalidomide is also being tested as a potential treatment for COVID-19. Thalidomide infamously caused thousands of birth defects to babies who were exposed to the drug after their mothers took it to treat morning sickness between 1958-1962.
Original languageEnglish
Specialist publicationThe Conversation
PublisherThe Conversation UK
Publication statusPublished - 30 Apr 2020

Keywords

  • Immune system
  • Thalidomide
  • Coronavirus
  • COVID-19
  • inflammatory response

Fingerprint

Dive into the research topics of 'Despite thalidomide’s dark past, researchers are investigating it as a potential COVID-19 treatment'. Together they form a unique fingerprint.

Cite this